Fludara for intravenous infusion 50mg, from Sanofi, contains Fludarabine phosphate, a chemotherapy drug primarily used to treat B-cell chronic lymphocytic leukemia (CLL). It functions as a purine antimetabolite, inhibiting DNA synthesis and leading to cancer cell death. This injectable drug has a YJ code of 4229400D1033 and is standardized as 50mg 1 bottle.
Fludara for intravenous infusion 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →